2015 annual financial data
Travere Therapeutics 2015 Operating margin
Direct answer
Operating margin was -50.8%.
Operating income was -50,748,000 USD and net income was 117,237,000 USD.
Operating cash flow was -554,000 USD.
Get free Travere Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 99,892,000 USD
- Operating income
- -50,748,000 USD
- Net income
- 117,237,000 USD
- Operating cash flow
- -554,000 USD